Introduction
Members of the erbA gene family are candidates to play an important role in both differentiation and neoplasia. V-erbA is an avian retroviral oncogene that blocks erythroid differentiation and accelerates avian erythroleukemias (1) . A wide variety of animal tissues express a number of diverse erbA-related products, all of which include structural motifs common to known transcription factors (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) . Some ofthe erbA products have been demonstrated to encode a family of multiple different thyroid hormone receptors (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) . Thus, erbA gene products probably mediate thyroid hormone induction of tissuespecific genes necessary for differentiation of organs such as brain, heart, pituitary and liver (14) (15) (16) (17) . Finally, erbA products may mediate the documented activity ofthyroid hormone as a potentiator of carcinogens in some systems (18, 19) .
In man two active erbA-related loci, erbA-a and erbA-3, have been defined (2) (3) (4) (5) (6) . One human erbA-fi-and two different human erbA-a-encoded cDNAs have been cloned and shown to encode different thyroid hormone-binding proteins (2) (3) (4) (5) (6) . Each of these erbA cDNAs hybridizes to multiple different size mRNA transcripts, which are differently expressed in different tissues (2) (3) (4) (5) (6) . Human erbA-f transcripts of 2 and 6 kb, and human erbA-a transcripts of 3.2, 2, 2.5, and 5 kb, have all been identified (3, (5) (6) (7) .
This study was undertaken to determine the pattern of erbA products expressed in both normal and neoplastic colon.
We found that in normal colon mucosa one erbA-#-and two erbA-a-related transcripts were expressed. The same transcripts were also expressed in tissue from one patient's colon polyp and in adenomatous epithelium cultured from a second patient's colon polyp. In contrast, in colon carcinoma tissue expression of the erbA-f transcript was markedly and specifically diminished. Loss of erbA-0 expression was not accompanied by erbA-i3 gene deletion. Loss of erbA-f3 expression is a novel marker of malignant transformation in the colon and may play a role in mediating the transformed phenotype ofthe colon carcinoma cell.
Methods
Cell lines. The VACO 330 cell line was maintained in MEM supplemented with 2% fetal bovine serum and hormones as described (20) .
Tissue samples. Colectomy samples were received on ice directly from the operating room. Tissue sections of grossly obvious neoplasm were immediately dissected by the attending pathologist. Adjacent sections were submitted for histologic analyses and microscopic confirmation that the tissue contained predominantly neoplastic cells. Samples of noninvolved mucosa were immediately removed from the resection margin of the surgical specimen by blunt dissection of the mucosa off the muscularis mucosa.
Nucleic acids. Tissue samples were immediately homogenized in guanidine isothiocyanate using an electric tissue grinder (21) . RNA was also extracted from the VACO 330 cell line by dissolving the cells in guanidine isothiocyanate (21, 22) . Total RNA and DNA were separated by ultracentrifugation of the extract through a cesium cushion (21, 22) . Total RNA was resolved by electrophoresis on agarose-formaldehyde gels and judged to be undegraded based on the relative ethidium staining of 28S and 18S subunits (21, 22) . Polyadenylated mRNA was selected by chromatography on oligo-dT cellulose (21, 22) . DNAs were dissolved in SDS, digested with proteinase K, and extracted with phenol plus chloroform (21, 22) .
Northern analysis. 2 ,ug of polyadenylated mRNA was resolved by electrophoresis on agarose-formaldehyde gels (22) . RNA was transcDNA probes were labeled with 32P by the random primer technique (23) . Hybridization of probe to filters was at 42°C in 50% formamide, 5X SSPE, 2X Denhardt's, 0.1% SDS, and 0.1 mg/ml salmon sperm DNA. Final washes were in 0.1 X SSC and 1% SDS. Blots were exposed on XAR film (Eastman Kodak Co., Rochester, NY) with an intensifying screen.
Southern analyses. 10 ,ug of genomic DNA was cut with restriction enzymes, resolved by agarose gel electrophoresis, and transferred to nitrocellulose membranes (21, 22) . Labeling of probe and hybridization of blots were as described above.
Probes. Northern probes constructed from human erbA-13 placental clone pheA12 (3) included: probe 1, a near full-length 1.3-kb Eco RI-Bgl II fragment spanning all but the carboxyl terminus of the coding region; probe 2, a 0.3-kb Eco RI-Sst I fragment spanning the NH2 terminus of the coding region; and probe 3, a 0.15-kb Bgl II-Eco RI fragment spanning the COOH terminus of the coding region. An additional erbA-,B probe, pBH302, detects several restriction fragment length polymorphisms (RFLPs)' at the 5' end of the erbA-3 gene (24) (25) (26) . The erbA-a probe used was a Bgl I-Hinc II fragment of rat brain clone rbeA 12 (8) spanning all but the carboxyl terminus of the coding region. The glyceraldehyde-3-phosphate dehydrogenase (GAPDH) probe used was a Pst I fragment from a chicken muscle cDNA clone (27) . Stringencies for washing blots were: erbA-13 probes, 65°C; erbA-a probe, 60°C; and GAPDH probe, 56°C.
Results
Three erbA-related transcripts are expressed in cultured colonic adenomatous epithelium. We initially characterized erbA transcripts expressed in VACO 330, a cell culture model ofthe nonmalignant colon epithelial cell. VACO 330, an immortal culture established from a human colonic tubular adenoma, grows as a differentiated epithelial sheet with basal nuclei, apical microvilli, and tight junctions (20) . The cell line does not clone in soft agar and is not tumorigenic when injected into the nude mouse (20) . VACO 330 thus provides a unique culture model of the nonmalignant human colonic epithelial cell. Fig. 1 shows the expression ofthree erbA-related transcripts detected by Northern analysis of RNA from VACO 330. Hybridization of 2 ,ug of VACO 330 polyadenylated mRNA to erbA-,B probe 1, a 1.3-kb fragment of human placental erbA-1 cDNA pheA12 (3), detected in VACO 330 a 6-kb transcript. Two additional transcripts of 5.2 and 2.7 kb were identified by hybridization of an identical sample to a rat brain erbA-a cDNA (8 Human placental erbA-13 cDNA pheA12, a 1.7-kb cDNA, was previously shown in HeLa and MCF7 cell lines to hybridize to a 2-kb transcript, and, in human placental RNA, to hybridize to multiple transcripts of 5, 3, 2.5, and 2 kb (3). A 6-kb transcript was detected in VACO 330 using as a hybridization probe either erbA-13 probe 1, which spans nearly the complete coding region from placental cDNA pheA 12 (Fig. 1) , or using erbA-,B probes 2 and 3, derived from the amino and carboxyl terminus of the placental erbA-1 coding region (data not shown). Thus the colonic 6-kb transcript shares homology 1 . Abbreviations used in this paper: GAPDH, glyceraldehyde-3-phosphate dehydrogenase; RFLP, restriction fragment length polymorphism. with the placental erbA-13 cDNA throughout the coding region, but clearly must contain additional sequence information.
Two erbA-a transcripts and one erbA-# transcript are expressed in normal colonic mucosa. Expression of the erbA-13-related transcript is specifically lost in colon carcinoma. To determine if erbA transcripts expressed in VACO 330 are representative of erbA transcripts expressed in intact human colon mucosa, we next characterized erbA expression in normal and neoplastic colon tissue. Matched samples of neoplastic and noninvolved mucosa were obtained from colectomy specimens from nine patients. As shown in Table I , eight patients had colon cancer, which in seven cases had spread to regional lymph nodes or distant sites at the time of initial surgery. Fig. 2 shows expression of erbA -a-and erbA-fl-related transcripts in these samples examined by Northern analysis on duplicate filters. Fig. 2 shows that the 6-kb erbA-ft transcript expressed by VACO 330 was also expressed in noninvolved colon mucosa from each of eight patients; interestingly, however, this transcript was absent or markedly diminished in each of these patients' colon cancers (patients 2-9). In con- Also in contrast to the loss of erbA-# expression in colon carcinoma, Fig. 2 demonstrates maintenance of erbA-ft expression in a villous polyp. Expression oferbA-related alleles in the polyp tissue from patient 1 is similar to expression of erbA alleles in VACO 330, a pure epithelial culture previously established from a colonic tubular adenoma. These data suggest that the loss of erbA-(3 expression in colon carcinoma occurs within the malignant epithelial cell.
To insure that comparable amounts of mRNA from both tumor and noninvolved mucosa were applied, filters were stripped and rehybridized to a cDNA probe for GAPDH (Fig.  2) . GAPDH, a "housekeeping enzyme," which is equally expressed in both proliferating and nonproliferating cells (28) (24) (25) (26) . Genomic DNA from colon carcinomas and noninvolved colon mucosa were therefore digested separately with Hind III, Msp I, and Dra I, and compared after Southern hybridization to probe pBH302. Of the eight patients, five were heterozygous for at least one RFLP. Heterozygosity was retained in the tumor tissue in each of the informative patients (data not shown). Potentially, DNA extracted from nonneoplastic cells in the tumor samples might partially mask allelic loss in the neoplastic cells. However, there was no suggestion in any of the heterozygotes of any decrease in relative intensity of an allele in the tumor sample compared with its intensity in the normal control. Additionally, DNA from colon carcinoma and noninvolved mucosa was also digested with Eco RI and examined by Southern hybridization to erbA-( cDNA probe 1. The expected four genomic bands (30) were detected and there was no evidence of erbA-3 gene rearrangement in any of the tumor samples (data not shown).
Discussion
These data identify three erbA transcripts that are normally expressed in human colon mucosa, and demonstrate that loss of expression of a 6-kb erbA-( transcript is a novel marker for colon carcinoma. These data also provide a structural basis for thyroid-mediated responses in human colon. As three different erbA transcripts are detected, human colon mucosa may contain as many as three distinct thyroid hormone receptors.
This study provides the first characterization of the tissuespecific expression of erbA-related transcripts in human colon. liver (3, 7) . In the rat, alternate splicing of the primary erbA-# transcript gives rise to distinct erbA-(l and erbA-32 transcripts (9) . Alternate splicing may similarly account for the multiple-sized human erbA-# transcripts detected by different laboratories. The relation ofthe colonic 2.7-and 5.2-kb transcripts to previously identified erbA-a transcripts remains to be clarified. To date, two human erbA-a class cDNAs, erbA-a 1 and erbA-a2, have been cloned, shown to arise from alternate RNA splicing, and demonstrated to encode thyroid hormone binding proteins (5, 6) . In rat, additional erbA-a-related cDNAs have been cloned and shown to encode not thyroid receptors but thyroid receptor antagonists (10) (11) (12) . In man, a 3.2-kb erbA-al transcript is present in kidney, placenta, tonsil, and spleen (5). ErbA-a2 transcripts of 2, 2.5, and 5 kb are expressed in multiple human tissues (6) . Further study of the structure and function of the colonic erbA-a transcripts will provide additional characterization of the rapidly growing erbA family.
We find one colonic erbA transcript, a 6-kb erbA-# transcript, to be notably diminished in colon cancer. Decreased expression of this transcript is found in colon cancers from each of the eight patients examined in this study. However, seven of the eight primary colon carcinomas examined in this study were (29) . Changes in transcription of the erbA-gene or in stability ofthe erbA-( transcript probably account for the diminished erbA-,B expression in colon carcinoma.
Loss of erbA-(3 expression is a novel marker for colon carci- 
